Polycystic ovary syndrome (PCOS) is a common and highly heterogeneous endocrine–metabolic disorder. The Rotterdam criteria identify four diagnostic phenotypes; however, it remains unclear whether these phenotypes or body mass index (BMI) better predict metabolic risk. The PCOSOUTCOME.net registry collects data from mul...
A. Gambineri, S. Federici, E. Maseroli et al.· Journal of Endocrinological...· 0 citations
Obesity and Polycystic Ovary Syndrome (PCOS) share key pathophysiological mechanisms, including insulin resistance, hyperandrogenism and hypothalamic-pituitary-ovarian axis dysfunction. In literature, it is debated whether gonadal alterations in PCOS with and without obesity arise from distinct pathophysiological...
C. Manzini, Elisa Delle Donne, Emma Dorato et al.· European Journal of Endocrin...· 0 citations
Male hypogonadism is increasingly prevalent with advancing age and is particularly frequent among men with obesity, type 2 diabetes mellitus, and other cardiometabolic comorbidities (functional hypogonadism), whereas it remains relatively uncommon in younger men except in the presence of congenital or acquired disorder...
Serena Anna Ravelli, E. Maseroli, Linda Vignozzi· Maturitas· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.